A Phase 4 study on the effect of ketamine and etomidate during RSI on long-term outcomes

Study Description

Evaluating the impact of ketamine and etomidate on reducing post-traumatic stress disorder (PTSD) after critical illness and intubation

Study Details

Registry ID:

NCT06179485

Conditions:

Post-Traumatic Stress Disorder, Acute Respiratory Failure

Phase:

Target Enrollment:

1,756 participants

Start Date:

April 6, 2022

Healthy Volunteers:

No

Study Locations (6 sites)

• Wake Forest Baptist Medical Center
  Winston-Salem, North CarolinaUnited States, United States
• University of Alabama Hospital
  Birmingham, AlabamaUnited States, United States
• Vanderbilt University Medical Center
  Nashville, TennesseeUnited States, United States
• Hennepin County Medical Center
  Minneapolis, MinnesotaUnited States, United States
• University of Colorado Denver
  Aurora, ColoradoUnited States, United States
• Denver Health Medical Center
  Denver, ColoradoUnited States, United States

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →